Use of Recombinant Factor VIIa for Major Elective Surgery in a Patient with Factor VII Deficiency, Retroperitoneal Fibrosis and Hydronephrosis-Reference-Cited by-同舟云学术

Use of Recombinant Factor VIIa for Major Elective Surgery in a Patient with Factor VII Deficiency, Retroperitoneal Fibrosis and Hydronephrosis

Published:1997-01 Issue:1 Volume:3 Page:33-35
ISSN:1076-0296
Container-title:Clinical and Applied Thrombosis/Hemostasis
language:en
Short-container-title:Clin Appl Thromb Hemost

Author:

Cobos Everardo¹,Keung Yi-Kong²,Akhter Saeed²,Jones Jeff¹

Affiliation:

1. Division of Oncology/Hematology, Texas Tech University Health Sciences Center, Lubbock, Texas, U.S.A.

2. Department of Urology, Texas Tech University Health Sciences Center, Lubbock, Texas, U.S.A.

Abstract

We described a case of obstructive uropathy due to retroperitoneal fibrosis associated with congenital factor VII deficiency. Nephrectomy and ileoureter reconstruction was performed uneventfully using recombinant factor Vlla perioperatively. There was no excessive bleeding or thrombosis. Key Words: Recombinant factor Vlla-rFVlla-Retroperitoneal fibrosis-Factor VII deficiency.

Publisher

SAGE Publications

Subject

Hematology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/107602969700300104

Reference13 articles.

1. Roberts HR, Lefkowitz JB: Inherited disorders of prothrombin conversion. In: Colman RW, Hirsh J, Marder VJ, et al., eds, Hemostasis and Thrombosis. Basic Principles and Clinical Practice. 3rd ed. Philadelphia: J.B. Lippincott Company , 1994, p. 200-9.

2. IDIOPATHIC RETROPERITONEAL FIBROSIS ASSOCIATED WITH A COAGULATION DEFECT (FACTOR VII DEFICIENCY): REPORT OF A CASE AND REVIEW OF THE LITERATURE

3. Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor

4. Control of haemostasis with recombinant factor VIIa in patient with inhibitor to factor VIII

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3D-QSAR, docking and molecular dynamics for factor Xa inhibitors as anticoagulant agents;Molecular Simulation;2013-05

2. Klinische Bewertung potentieller Einsatzbereiche von rekombinantem Faktor VIIa bei internistischen und pädiatrischen Erkrankungen;Medizinische Klinik;2007-01

3. Congenital factor VII deficiency: therapy with recombinant activated factor VII - a critical appraisal;Haemophilia;2006-01

4. Efficacy and safety of recombinant factor VIIa preparation (NovoSeven) for patients with congenital factor VII deficiency;Japanese Journal of Thrombosis and Hemostasis;2006

5. Mechanism of blood coagulation. Newer aspects of anticoagulant and antithrombotic therapy;Acute Pulmonary Embolism;2000